PVR and preeclampsia: However, numerous studies, especially in tumor immunology, investigated TIGIT, CD226, CD112, and CD155 immune checkpoint molecules and their possible role in immunoregulation while much fewer papers have been published in the context of pregnancy; moreover, there is no published data related to EO preeclampsia.